Complementary Therapies in Equine Care: What Horse Owners Need to Know – thehorse.com
Complementary Therapies in Equine Care: What Horse Owners Need to Know thehorse.com >View original article Contributor:
Daily oral GLP-1 pill a promising alternative to injectables for weight loss, clinical trial finds – Medical Xpress
Daily oral GLP-1 pill a promising alternative to injectables for weight loss, clinical trial finds Medical Xpress >View original article Contributor:
Trump’s Obamacare fix: Send consumers money, not insurance companies – USA Today
Trump’s Obamacare fix: Send consumers money, not insurance companies USA Today >View original article Contributor:
I cover maternal health. Here’s my plan to ensure hospital staff listen when I’m in labor.
Experts provide tips on how to protect yourself during labor and delivery, including asking questions and seeking a second opinion when necessary. View original article Contributor: Sabrina Malhi
Bird flu patient dies, marking second U.S. fatality in 2025
The Washington state resident, an older adult with underlying conditions, was infected with a strain that has previously been reported in animals but never before in humans. View original article Contributor: Lena H. Sun
Cassidy’s health care alternative – Invest in Louisiana
Cassidy’s health care alternative Invest in Louisiana >View original article Contributor:
Functional Medicine: Pseudoscientific Silliness – Skeptic
Functional Medicine: Pseudoscientific Silliness Skeptic >View original article Contributor:
Caribou Medical Center to launch Longevity and Wellness Clinic in Soda Springs – The Herald Journal
Caribou Medical Center to launch Longevity and Wellness Clinic in Soda Springs The Herald Journal >View original article Contributor:
Top FDA drug regulator raises alarms about expediting approvals
Richard Pazdur, who assumed his new role this month, has warned that new Trump administration initiatives could be illegal and pose a risk to public health. View original article Contributor: Dan Diamond, Rachel Roubein
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Value
The 150-year-old drugmaker is the first company in health care to hit the milestone. View original article Contributor: Rebecca Robbins